ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,753Medicare Part D Prescriptions Filled, Including Refills

Rank: 70 out of 1456

$994K Total Retail Price of All Prescriptions

Rank: 113 out of 1456

663 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 663 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

24% of this provider’s 663 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

4% of this provider’s 17,217 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
LEVOTHYROXINE SODIUM 960 847 1 4
HYDROCODONE-ACETAMINOPHEN 825 635 S3 2 6
SIMVASTATIN 720 574 3 2
AMLODIPINE BESYLATE 622 532 4 1
OMEPRAZOLE 576 416 5 5
POTASSIUM CHLORIDE 477 383 6 15
NEXIUM 396 321 7 23
ZOLPIDEM TARTRATE 384 281 8 14
METFORMIN HCL 375 253 9 8
METOPROLOL TARTRATE 372 295 10 12
MELOXICAM 353 273 11 30
FUROSEMIDE 344 265 12 7
LISINOPRIL-HYDROCHLOROTHIAZIDE 336 272 13 24
METOPROLOL SUCCINATE 332 267 14 19
GABAPENTIN 326 239 15 13
LOSARTAN-HYDROCHLOROTHIAZIDE 282 218 16 41
LISINOPRIL 247 191 17 3
CYCLOBENZAPRINE HCL 244 165 R 18 66
PRAVASTATIN SODIUM 243 217 19 9
ATORVASTATIN CALCIUM 231 189 20 11
CITALOPRAM HBR 221 197 21 22
TRAMADOL HCL 212 157 22 17
PREDNISONE 208 160 23 42
METHYLPREDNISOLONE 207 154 24 106
FLUTICASONE PROPIONATE 206 138 25 28
RANITIDINE HCL 200 147 26 27
HYDROCHLOROTHIAZIDE 173 125 27 10
SERTRALINE HCL 172 158 28 25
WARFARIN SODIUM 172 172 28 21
AZITHROMYCIN 166 123 30 44
FAMOTIDINE 163 129 31 45
AMITRIPTYLINE HCL 162 126 R 32 70
ATENOLOL 161 161 33 18
MECLIZINE HCL 156 141 34 101
LEVOFLOXACIN 156 118 34 79
BUMETANIDE 144 112 36 191
PAROXETINE HCL 143 118 37 67
CARVEDILOL 140 97 38 20
AMLODIPINE BESYLATE-BENAZEPRIL 139 136 39 61
ALENDRONATE SODIUM 134 123 40 36
PROAIR HFA 126 63 41 69
DIGOXIN 125 121 42 62
ALLOPURINOL 124 100 43 31
CLOPIDOGREL 123 112 44 32
COMBIVENT 122 82 45 110
LOSARTAN POTASSIUM 117 103 46 16
DONEPEZIL HCL 116 116 47 29
PLAVIX 112 101 48 46
VERAPAMIL ER 112 97 48 82
ADVAIR DISKUS 109 59 50 63
CLONIDINE HCL 109 86 50 39
CLEMASTINE FUMARATE 108 86 R 52 259
BENAZEPRIL HCL 101 98 53 57
POLYETHYLENE GLYCOL 3350 98 86 54 85
SPIRIVA 97 77 55 75
TRIAMTERENE-HCTZ 96 72 56 49
GLIMEPIRIDE 95 82 57 33
CYMBALTA 92 44 58 52
TIZANIDINE HCL 90 74 59 116
SINGULAIR 89 77 60 83
VOLTAREN 89 72 60 214
LOVASTATIN 85 56 62 40
ISOSORBIDE MONONITRATE ER 83 67 63 60
TAMSULOSIN HCL 82 80 64 34
ROPINIROLE HCL 80 58 65 90
LIPITOR 80 46 65 76
LORAZEPAM 79 76 67 236
TRAZODONE HCL 78 55 68 47
CIPROFLOXACIN HCL 77 61 69 58
CLOTRIMAZOLE-BETAMETHASONE 76 57 70 163
FLUCONAZOLE 76 61 70 148
PANTOPRAZOLE SODIUM 74 53 72 43
INSULIN SYRINGE 73 58 73 64
OXYCODONE HCL-ACETAMINOPHEN 73 61 S2 73 132
PROMETHAZINE HCL 73 45 R 73 77
TRICOR 73 50 73 92
FENOFIBRATE 71 31 77 56
CELEBREX 71 63 77 88
NOVOLOG MIX 70-30 70 60 79 204
JANUVIA 70 49 79 68
METOCLOPRAMIDE HCL 69 67 81 125
DIOVAN 68 48 82 35
DIOVAN HCT 67 50 83 59
MIRTAZAPINE 66 46 84 65
BENAZEPRIL-HYDROCHLOROTHIAZIDE 66 58 84 177
PREMARIN 65 64 R 86 99
ESTRADIOL 65 35 R 86 153
NOVOLIN 70-30 64 52 88 144
VENTOLIN HFA 64 40 88 121
DILTIAZEM ER 62 51 90 147
TRIAMCINOLONE ACETONIDE 62 50 90 158
OXYBUTYNIN CHLORIDE ER 60 58 92 167
QUETIAPINE FUMARATE 60 60 92 78
NAPROXEN 60 43 92 100
FENTANYL 59 58 S2 95 114
OXYCODONE-ACETAMINOPHEN 58 44 S2 96 109
DILTIAZEM 24HR ER 58 58 96 126
GLIPIZIDE XL 57 33 98 134
RISPERIDONE 56 38 99 72
KLOR-CON 10 56 52 99 96
CRESTOR 56 40 99 26
ALPRAZOLAM 56 56 99 149
MONTELUKAST SODIUM 55 51 103 135
EVISTA 54 54 104 113
FLUOXETINE HCL 53 30 105 55
NIFEDIPINE ER 52 49 106 81
DILT-XR 52 42 106 487
GLYBURIDE-METFORMIN HCL 51 44 R 108 119
CEPHALEXIN 51 36 108 123
DOXAZOSIN MESYLATE 50 46 110 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.